ClinicalTrials.Veeva

Menu

The Alouette Test in Parkinson Disease (REPEAT)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Parkinson Disease

Treatments

Other: Alouette test (reading test)

Study type

Observational

Funder types

Other

Identifiers

NCT03958175
REPEAT (Other Identifier)

Details and patient eligibility

About

Reading disorders in Parkinson's Disease (PD) are poorly evaluated due to the lack of validated tests to screen for them. They are often attributed to hand tremors associated with the disease. In this study, the investigating team evaluated the "alouette test" validated for dyslexia screening, in PD by comparing the results to healthy patients.

Enrollment

38 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Parkinson's Disease
  • Montreal Cognitive Assessment (MoCA) test > 20

Exclusion criteria

  • Patient's with supranuclear Palsy
  • Other neurologic disease
  • Any ophthalmologic disease
  • Presence of a nystagmus
  • Visual acuity < 0.6

Trial design

38 participants in 2 patient groups

Patients with Parkinson's Disease
Description:
Patients with Parkinson's Disease (PD) were evaluated for reading disorders using a screening method validated for dyslexia.
Treatment:
Other: Alouette test (reading test)
Patients without Parkinson's Disease = control group
Description:
Patients without Parkinson's Disease (PD) were evaluated for reading disorders using a screening method validated for dyslexia.
Treatment:
Other: Alouette test (reading test)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems